INTERNATIONAL PATENT: THE UNIVERSITY OF CHICAGO FILES APPLICATION FOR "TARGETING TET2 ENZYME FOR TREATING HEMOGLOBINOPATHIES"

GENEVA, Oct. 20 -- THE UNIVERSITY OF CHICAGO (5801 S. Ellis AvenueChicago, Illinois 60637) filed a patent application (PCT/US2025/023434) for "TARGETING TET2 ENZYME FOR TREATING HEMOGLOBINOPATHIES" on Apr 07, 2025. With publication no. WO/2025/217043, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WICKREMA, Amittha (c/o The University of Chicago5801 S. Ellis AvenueChicago, Illinois 60637), JEONG, Jong Jin (c/o The University of Chicago5801 S. Ellis AvenueChicago, Illinois 60637), DAS, Trinath P. (c/o The University of Ch...